In vivo antitumor effect of canstatin gene on human esophageal carcinoma xenografts in nude mice

Chinese Journal of Cancer

Volumn 28, Issue 4, 2009, Pages 1-7

  Zheng, Xiang Wei ^a   Li, Yin ^b   Tang, Fu Ai ^a   Ma, Jun ^a   Zheng, Peng Yuan ^a   Lu, Gao Feng ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Henan Provincial Cancer Hospital   (China)

Author keywords

Canstatin; Caspase 3; Esophageal neoplasm; Flk 1; Gene therapy; Nude mouse; VEGF; Xenograft

Indexed keywords

ADENOVIRUS VECTOR; CANSTATIN; CASPASE 3; FETAL LIVER KINASE 1; GREEN FLUORESCENT PROTEIN; PHOSPHATE BUFFERED SALINE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ESOPHAGUS CARCINOMA; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MICROVASCULATURE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUDE MOUSE; PROTEIN EXPRESSION; TISSUE NECROSIS; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION;

EID: 79955777625     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Narazaki M, Tosato G. Canstatin: an inhibitor of angiogenesis and tumor growth revisited [J]. Cancer J, 2006, 12 (2): 110-112.
2. Kamphaus GD, Colorado PC, Panka DI, et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth [J]. J Biol Chem, 2000, 275(2): 1209-1215.
3. Hou WH, Wang TY, Yuan BM, et al. Recombinant mouse canstatin inhibits chicken embryo chorioallantoic membrane angiogenesis and endothelial cell proliferation [J]. Acta Biochim Biophys Sin (Shanghai), 2004, 36(12): 845-850.
4. Li YY, Qian GS, Huang GJ, et al. Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model [J]. Cancer J, 2006, 12(2): 136-146.
5. He XP, Li ZS, Zhu RM, et al. Effects of recombinant human canstatin protein in the treatment of pancreatic cancer [J]. World J Gastroenterol, 2006, 12(41): 6652-6657.
6. Folkman J. Tumor angiogenesis: therapeutic implications [J]. N Engl J Med, 1971, 285(21): 1182-1186.
7. Du JR, Jiang Y, Zhang YM, et al. Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas [J]. World J Gastroenterol, 2003, 9 (7): 1604-1606.
8. Cavallaro U, Christofori G. Molecular mechanisms of tumor angiogenesis and tumor progression [J]. J Neurooncol, 2000, 50(1-2): 63-70.
9. Conti CJ. Vascular endothelial growth factor: regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy [J]. Oncologist, 2002, 7(3): 4-11.
10. Bandoh H, Hayashi T, Takahara M, et al. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis [J]. Cancer Lett, 2004, 208(2): 215-225.
11. Qin RY, Fang RL, Gupta MK, et al. Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis [J]. World J Gastroenterol, 2004, 10 (1): 132-135.
12. Kieran MW, Billett A. Antiangiogenesis therapy. Current and future agents [J]. Hematol Oncol Clin North Am, 2001, 15 (5): 835-851.
13. Davis DW, McConkey DJ, Abbruzzese JL, et al. Surrogate markers in antiangiogenesis clinical trials [J]. Br J Cancer, 2003, 89(1): 8-14.
14. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration [J]. N Engl J Med, 2004, 351 (27): 2805-2816.
15. Wang WB, Zhou YL, Heng DF, et al. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice [J]. Breast Cancer Res Treat, 2008, 110 (2): 283-295.
16. Magnon C, Opolon P, Connault E, et al. Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment [J]. Gene Ther, 2008, 15(21): 1436-1445.
17. Goto T, Ishikawa H, Matsumoto K, et al. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis [J]. Int J Oncol, 2008, 33(1): 33-40.
18. Chung IS, Son YI, Ko YJ, et al. Peritumor injections of purified tumstatin delay tumor growth and lymphatic metastasis in an orthotopic oral squamous cell carcinoma model [J]. Oral Oncol, 2008, 44(12): 1118-1126.
19. Yue T, Zhang P, Liu P, et al. Effect of transfection of hEndostatin gene on CNE2 cell xenograft growth in nude mice [J], Aizheng, 2003, 22(2): 148-151. [in Chinese]
20. Zhang GF, Wang YH, Zhang MA, et al. Inhibition of growth and metastases of human colon cancer xenograft in nude mice by angiogenesis inhibitor endostatin [J], Aizheng, 2002, 21(1): 50-53. [in Chinese]
21. Mellon MJ, Ahm M, Jimenez JA, et al. Antiangiogenic gene therapy for metastatic renal cell carcinoma produces tumor growth suppression in an athymic nude mouse model [J], J Urol, 2008, 179(2): 737-742.
22. Ding XQ, Chen Y, Li L, et al. Inhibition of tongue cancer development in nude mice transfected with adenovirus carrying human endostatin gene [J]. Aizheng, 2003, 22(11): 1152-1157. [in Chinese]
23. Cao Y, Li S, Li HL, et al. Clinical tolerance trial on recombinant human endostatin adenovirus [J]. Aizheng, 2007, 26 (8): 856-860. [in Chinese]
24. Su C, Na M, Chen J, et al. Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy [J]. Mol Cancer Res, 2008, 6 (4): 568-575.
25. Isayeva T, Chanda D, Kallman L, et al. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model [J]. Cancer Res, 2007, 67(12): 5789-5797.
26. Enari M, Sakahira H, Yokoyama H, et al. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitors ICAD [J]. Nature, 1998, 391 (6662): 43-50.
27. Wolf BB, Schuler M, Echeverri F, et al. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor 45/inhibitor of caspase-activated DNase activation [J]. J Biol Chem, 1999, 274(43): 30651-30656.
28. Magnon C, Galaup A, Mullan B, et al. Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins [J]. Cancer Res, 2005, 65(10): 4353-4361.